Evaluating Treatment Prioritization Rules via Rank-Weighted Average Treatment Effects

Area of Science:

• Biostatistics
• Health Services Research
• Clinical Trial Design

Background:

• Existing methods for prioritizing treatment lack a unified evaluation framework.
• Current approaches include treatment effect estimation, risk scoring, and rule-based systems.
• A need exists for a general metric to assess the performance of treatment prioritization rules.

Purpose of the Study:

• To introduce rank-weighted average treatment effect (RATE) metrics for evaluating treatment prioritization rules.
• To provide a general and flexible framework for comparing the effectiveness of different targeting strategies.
• To enable robust statistical inference for these metrics across various study designs.

Main Methods:

• Defined a family of rank-weighted average treatment effect (RATE) estimators.
• Proved a central limit theorem for asymptotically exact inference.
• Demonstrated that RATE metrics generalize existing measures like the Qini coefficient.

Main Results:

• RATE metrics provide a unified approach to assess treatment prioritization.
• The proposed estimators allow for valid statistical inference in randomized and observational studies.
• The framework is applicable to diverse clinical scenarios, including optimal drug targeting.

Conclusions:

• RATE metrics offer a simple, general, and powerful tool for evaluating treatment prioritization.
• This framework facilitates the comparison and improvement of strategies for identifying patients who benefit most from treatment.
• The methodology supports evidence-based decision-making in clinical practice and policy.